The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist.
O'Malley
Patricia
P
Miami Valley Hospital, Dayton, Ohio 45409, USA. pomalley@mvh.org
D016907:Adverse Drug Reaction Reporting Systems; D002908:Chronic Disease; D017277:Drug Approval; D004348:Drug Labeling; D011307:Drug Prescriptions / Q000451:nursing / Q000706:statistics & numerical data; D004363:Drug Utilization / Q000706:statistics & numerical data; D058785:GABA-A Receptor Agonists; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D009720:Nurse Clinicians; D024802:Nurse's Role; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011358:Product Surveillance, Postmarketing; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications / Q000188:drug therapy* / Q000453:epidemiology / Q000451:nursing; D013009:Somnambulism / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration
D058785:GABA-A Receptor Agonists; D006993:Hypnotics and Sedatives